1. Home
  2. ATAI vs FLYX Comparison

ATAI vs FLYX Comparison

Compare ATAI & FLYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATAI
  • FLYX
  • Stock Information
  • Founded
  • ATAI 2018
  • FLYX 2015
  • Country
  • ATAI Germany
  • FLYX United States
  • Employees
  • ATAI N/A
  • FLYX N/A
  • Industry
  • ATAI Biotechnology: Pharmaceutical Preparations
  • FLYX Blank Checks
  • Sector
  • ATAI Health Care
  • FLYX Finance
  • Exchange
  • ATAI Nasdaq
  • FLYX Nasdaq
  • Market Cap
  • ATAI 282.6M
  • FLYX 264.1M
  • IPO Year
  • ATAI 2021
  • FLYX N/A
  • Fundamental
  • Price
  • ATAI $1.41
  • FLYX $3.01
  • Analyst Decision
  • ATAI Strong Buy
  • FLYX
  • Analyst Count
  • ATAI 3
  • FLYX 0
  • Target Price
  • ATAI $10.50
  • FLYX N/A
  • AVG Volume (30 Days)
  • ATAI 1.4M
  • FLYX 6.3K
  • Earning Date
  • ATAI 05-19-2025
  • FLYX 01-01-0001
  • Dividend Yield
  • ATAI N/A
  • FLYX N/A
  • EPS Growth
  • ATAI N/A
  • FLYX N/A
  • EPS
  • ATAI N/A
  • FLYX N/A
  • Revenue
  • ATAI $308,000.00
  • FLYX $327,274,000.00
  • Revenue This Year
  • ATAI $65.58
  • FLYX $28.47
  • Revenue Next Year
  • ATAI N/A
  • FLYX $22.44
  • P/E Ratio
  • ATAI N/A
  • FLYX N/A
  • Revenue Growth
  • ATAI N/A
  • FLYX 3.78
  • 52 Week Low
  • ATAI $1.03
  • FLYX $1.79
  • 52 Week High
  • ATAI $2.57
  • FLYX $8.39
  • Technical
  • Relative Strength Index (RSI)
  • ATAI 44.57
  • FLYX 50.82
  • Support Level
  • ATAI $1.36
  • FLYX $2.92
  • Resistance Level
  • ATAI $1.54
  • FLYX $2.98
  • Average True Range (ATR)
  • ATAI 0.09
  • FLYX 0.15
  • MACD
  • ATAI -0.00
  • FLYX 0.02
  • Stochastic Oscillator
  • ATAI 0.00
  • FLYX 76.53

About ATAI ATAI Life Sciences N.V.

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.

About FLYX flyExclusive Inc.

flyExclusive Inc is an owner and operator of curated private aviation experiences dedicated to surpassing passenger expectations for quality, convenience, and safety. Its mission is to be the world's majority vertically integrated private aviation company through capital-efficient program growth, an industry pricing model, optimal dispatch availability, in-house training, and a controlled premium customer experience on modernized aircraft. The company has over 90 aircraft in its owned and leased fleet which includes light, midsize, super-midsize, and large jets. As one of the nation's Citation operators, it has curated a versatile fleet of Citation CJ3/CJ3 plus, Citation Excel/XLS/XLS plus, Citation Encore/Encore plus, Citation Sovereign, and Citation X aircraft.

Share on Social Networks: